Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis.

Gupta S, Seshadri MR, Dandekar R, Müller-Jensen L, McCutcheon K, Scarffe LA, Vanasupa S, Sunahara M, Hayashi F, Caspar C, Lincoln R, Okinishi N, Thomas N, Shenoy S, Zylberman S, Fouassier C, Hassan E, Klauer S, Wilmoth J, Sabatino JJ, Bodansky A, Abdelhak A, Hauser SL, Wilson MR, Cree BAC